Post-Surgery Circulating Tumor Cells and <i>AXL</i> Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

Post-Surgery Circulating Tumor Cells and <i>AXL</i> Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

Background: The prognosis of early stage non-small cell lung cancer (NSCLC) is quite disappointing and the benefits of adjuvant therapy are relatively small. Thus, there is an urgent need to identify novel prognostic and predictive biomarkers. Lung adenocarcinoma has distinct clinical&#8722;path...

Full description

Bibliographic Details
Main Authors: Diego de Miguel-Pérez, Clara Isabel Bayarri-Lara, Francisco Gabriel Ortega, Alessandro Russo, María José Moyano Rodriguez, Maria Jesus Alvarez-Cubero, Elizabeth Maza Serrano, José Antonio Lorente, Christian Rolfo, María José Serrano
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Cancers
Subjects:
nsclc
axl
circulating tumor cells
prognosis
emt
adenocarcinoma
liquid biopsy
biomarkers
Online Access:https://www.mdpi.com/2072-6694/11/11/1750

Internet

https://www.mdpi.com/2072-6694/11/11/1750

Similar Items